| THIQ |
THIQ |
312637-48-2 |
| ESI 09 |
ESI-09 |
263707-16-0 |
| GS 143 |
4-(3-苄基-4-((5-(2-氟苯基)呋喃-2-基)亚甲基)-5-氧代-4,5-二氢-1H-吡唑-1-基)苯甲酸 |
916232-21-8 |
| 5-chloro-2-[(4-fluorophenyl)methylsulfonyl]-N-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidine-4-carboxamide |
PK11007;PK-11007;PK 11007 |
874146-69-7 |
| 4-(benzo[d]thiazol-2-ylthio)-3-chloroaniline |
4-(苯并[D]噻唑-2-基硫基)-3-氯苯胺 |
300809-71-6 |
| ML318 |
ML318 |
1610516-67-0 |
| JJKK 048 |
1515855-97-6 |
1515855-97-6 |
| INNO206 |
ALDOXORUBICIN |
1361644-26-9 |
| Ca2+ channel agonist 1 |
1402821-24-2 |
1402821-24-2 |
| EGFR-IN-7 (compound 34) |
5-溴-N4-[5-(二甲基膦基)-6-喹喔啉基]-N2-[2-甲氧基-5-甲基-4-[4-(4-甲基-1-哌嗪基)-1-哌啶基]苯基]-2,4-嘧啶二胺 |
2267329-76-8 |
| exo-IWR 1 |
exo-IWR 1 |
1127442-87-8 |
| MLS-573151 |
MLS-573151 |
10179-57-4 |
| STF 31 |
4-((4-(叔丁基)苯基磺酰胺基)甲基)-N-(吡啶-3-基)苯甲酰胺 |
724741-75-7 |
| MHY1485 |
MHY1485 |
326914-06-1 |
| ABT-199 |
ABT-199 |
1257044-40-8 |
| 4-BroMo-N-(4-broMophenyl)-3-[[(phenylMethyl)aMino]sulfonyl]benzaMide |
4-溴-N-(4-溴苯基)-3-[[(苯基甲基)氨基]磺酰基]苯甲酰胺 |
312756-74-4 |
| GSK-7975A |
1253186-56-9 |
1253186-56-9 |
| AC 186 |
化合物 T26537 |
1421854-16-1 |
| dBET6 |
1950634-92-0 |
1950634-92-0 |
| IAXO-102 |
IAXO-102 |
1115270-63-7 |
QQ
微信
